mi-BiomarK is a colorimetric miRNA detection kit for breast cancer.
Nuestros servicios
Breast cancer
Breast cancer is one of the most common and deadly forms of cancer due to its late diagnosis and rapid progression. Early detection is critical for improving survival rates and treatment outcomes.
miRNAs
MicroRNAs (miRNAs) are small, non-coding RNA molecules that play crucial roles in regulating gene expression. They are emerging as important biomarkers for various diseases, including pancreatic cancer, due to their presence in body fluids and their association with disease progression or even treatment resistance.
Early detection
Early detection of breast cancer significantly increases the chances of successful treatment. By identifying the disease at an earlier stage, patients can benefit from a wider range of therapeutic options and better prognoses.
Precision medicine
Precision medicine involves tailoring medical treatment to the individual characteristics of each patient. By using specific biomarkers like miRNAs for the diagnosis of breast cancer, mi-BiomarK aims to develop personalized diagnostic tools that enhance the accuracy and effectiveness of treatment plans, ensuring better outcomes for patients.
Benefits
1
Screening and follow-up patients
Patients with risk factors for breast cancer or patients undergoing breast cancer follow-up care, who express the need for less invasive detection methods. mi-BiomarK offers a test performed on a convenient blood sample.
2
Oncologist
For oncologists who need a method with high sensitivity and specificity for the diagnosis a monitoring of patients with breast cancer. Mi-BiomarK offers greater sensitivity and specificity than other blood-based methods. The ease of use and quick results of mi-BiomarK provide a significant time saving for oncologists with a busy schedule.
3
Diagnosis laboratories
Laboratories interested in implementing a diagnostic and monitoring method for a new segment of clients with suspected or ongoing breast cancer. Mi-BiomarK offers diagnostic laboratories a specific biomarker test for breast cancer that requires low-maintenance equipment, minimal training time, and quick execution. The blood sample used in mi-BiomarK can be drawn simultaneously with other tests, making it easy to add mi-BiomarK to a cancer diagnosis panel.
Advantages of mi-BiomarK
%2012_06_29.png)
Comparison with other detection methods
%2011_27_21.png)
Solution
Our innovative approach offers a unique solution in the market, setting us apart from traditional methods. Designed to be user-friendly, our kit requires no advanced technical knowledge, making it accesible for easy implementation in laboratories and clinics. With fast and accurate results, our solution is crucial for the early diagnosis and effective treatment of breast cancer.
Moreover, it is cost-effective, allowing medical and pharmaceutical institutions to save costs without compromising on diagnostic quality. Out solution us also scalable and adaptable, making it versatir for various medical settings.
By enhancing patient outcomes, our kit enables quicker, more precise diagnoses, paving the way for personalized treatments.
Developed in collaboration with field experts, our solution has a promising reliability and effectiveness.
Take a Closer Look
Testing procedures
%2013_32_58.png)
Result Interpretation
The colorimetric scale in our kit provides a simple and effective way to detect miRNAs associated with breast cancer. A detailed guide included in the box explains how to use the kit, while our app ensures medical professionals can accurately interpret the results for reliable diagnostics.
1
Colorimetric scale
2
Immediate results
3
Blue-to-red colors
%209_17_06.png)
4
Easy to interpret
5
In-box color reference